From metabolic normality to cardiometabolic risk factors in subjects with obesity (Q38326870)

2 September 2017

From metabolic normality to cardiometabolic risk factors in subjects with obesity (English)

1 reference

2 September 2017

1 reference

Elisabetta Bobbioni-Harsch

1

1 reference

2 September 2017

Zoltan Pataky

2

1 reference

2 September 2017

Vincent Makoundou

3

1 reference

2 September 2017

Martine Laville

4

1 reference

2 September 2017

Emmanuel Disse

5

1 reference

2 September 2017

Christian Anderwald

6

1 reference

2 September 2017

Thomas Konrad

7

1 reference

2 September 2017

Alain Golay

8

1 reference

2 September 2017

RISC Investigators

9

1 reference

2 September 2017

16 March 2012

1 reference

2 September 2017

1 reference

2 September 2017

20

1 reference

2 September 2017

2063-2069

1 reference

2 September 2017

10

1 reference

Characterizing the profile of obese patients who are metabolically healthy

2 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Open questions about metabolically normal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Can we identify metabolically healthy but obese individuals (MHO)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Prevalence of uncomplicated obesity in an Italian obese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Impact of BMI and the metabolic syndrome on the risk of diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Metabolic normality in overweight and obese subjects. Which parameters? Which risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

In vivo ultrasonic parametric imaging of carotid atherosclerotic plaque by videodensitometric technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

International physical activity questionnaire: 12-country reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Compendium of physical activities: an update of activity codes and MET intensities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

The utility of physical activity in the management of global cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Metabolically healthy but obese women: effect of an energy-restricted diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2012.69

31 March 2020

Identifiers

DOI

10.1038/OBY.2012.69

1 reference

2 September 2017

1 reference